Any thoughts on this company. Seemes to have good phase11 trail results in both their anti obesity drug and Irratable bowel syndrome drugs.
Much appreciated
Makes a change for a bio tech com to do well.
Thanks in advance

the share rise a lot today.

but still can`t find the true news in anywhere.

Apparently from the FT - can't find the original story, but gist was posted on Advfn

"Alizyme rose 4.1 per cent to 164p yesterday, having tripled in value since the start of August.
The rally has been driven by positive news flow for both its obesity therapy ATL-962 and Renzapride, its treatment for irritable bowel syndrome. Alizyme is unusual for a biotech company in having three products ready for final clinical trials, making it more likely to produce a marketable product than many of its peers.
Further progress for the shares may depend on Alizymes's ability to tie-up licensing agreements with local partners, although it could opt to enhance its appeal as a takeover candidate by retaining commercialisation rights.
... Sam Fazeli of Nomura estimates a deal would bring in $20-$30m initially and forecasts peak sales of 718m by 2010 if the obesity product can launch commercially. Nomura is also forecasting peak sales of 510m by 2010 for IBS treatment if a Licensing agreement can be conducted before its patent expires in 2007.
The Japanese bank also has a "buy" recommendation and has raised its target price to 220p, despite not expecting Alizyme to deliver profits before 2006."

I took profits and will wait for retrenchment to go back in. If there is not to be a prob with obesity which in the long term will cause major drain on NHS resources then the goverment will have to act. As it is, it is a major prob in the US.

Back up again.

still looking good....... nearly touching 2 pound today morning

over 2.00 mark. Now it has broken this mark where will stop. any ideas?

i hope it won`t stop......

still lots of ppl buy in AZM, still looking good to hold

At 200p it has to be pricing in some of the news to come - but there is a lot of good news to come - COLAL-PRED licensing soon, US/rest of world license for ATL-962, any licensing for renzapride....

My personal target is 300p+, but at the minute that's a gut feeling target rather than based on fact. One of the guys on the thread link in #7 has developed a pricing model spreadsheet.

Haven't seen it yet, but at worst should provide a basis for agreeing what a sensible price would be.

Without wanting to appear to be ramping this stock it is the best performer in my portfolio.

If they do get a licencing agreement with a firm like pfizer it would not be inconcievable to climb to a great hight after all you just have to think back when viagra hit the market. This is such an unknown quantity even if it has passed it's phase two trials.

After the hammering I got in the last two years I am looking forward to some respite.

it back to open level, I think it probably oversold. any idea?

What do you mean by "oversold"? In the normal usage of the term, there's no way on earth that a share hitting a 4-year high can be oversold - overbought yes, oversold, no.

If you mean that the selling to take the price to this level was overdone, well - I don't agree with that either :-)

As I've said before, nothing going up in a straight line, though AZM is having a damn good try. I wouldn't be at all sorry to see 150p or even 120p again - I would buy a shedload - and it could easily happen - the price has quadrupled in about 6 weeks, some retracing is inevitable, unless some more news is forthcoming. Now, AZM tend to release news on Fridays, and maybe there's been a leak of an announcement coming tomorrow? Or maybe, a lot of people want to get on a high-momentum train - some of whom will take a profit on the way and look for the next fast train, or look to get back onto this one.

Must admit, at 202p to sell, I was very tempted - as I was at 90p and the first time into 160p - but it's a dangerous game - all it needs is a really good announcement or a takeover bid and the price could jump 100p or more in a day.

-- washlander

"I took profits and will wait for retrenchment to go back in."
and
"it is the best performer in my portfolio"??

Are you in or out at the moment?

We took profits and came back in today.

16.03 hrs I cannot get to see the order books on level 11 can anybody help. Is it level two or something in the market

washlander,

Our suppliers are experiencing some difficulties, but are working to resolve them as we speak - I will keep you posted.

Ian

Thanks Ian

anything good news comming this week?

plenty, go buy it.